SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.26

107919.34

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.62

Back

Rossari Biotech consolidated net profit rises 4.39% in the September 2025 quarter

Oct 16,2025

Net profit of Rossari Biotech rose 4.39% to Rs 36.88 crore in the quarter ended September 2025 as against Rs 35.33 crore during the previous quarter ended September 2024. Sales rose 17.61% to Rs 586.11 crore in the quarter ended September 2025 as against Rs 498.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	586.11	498.35	18
OPM %	12.27	13.23	-
PBDT	67.91	63.27	7
PBT	49.67	48.11	3
NP	36.88	35.33	4

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)